million decreased by 7.18% from last year, due to the controlling of operating expenses. Administrative expenses presented at Baht 118.99 million, increased by 22.66% due to write off obsolete assets and
% 5.03% 5.71% 5.03% Return on Fixed Assets (ROFA) 26.77% 25.90% 26.77% 25.90% Debt/Equity Ratio 1.68 1.40 1.68 1.40 Net Debt/Equity Ratio 1.29 1.11 1.29 1.11 Leverage (Net Debt/EBITDA) 4.01 2.85 4.01 2.85
this year. During the first half of this year, the Company has recorded more provision of doubtful debt for THB. 2.6 million. In addition, advisory & other fee decreased by THB 1.3 million during 3Q17
in debt collection which the collection rate has increased by 97.2% at the end of March 2018. The Company expected that its performance in the first quarter of this year would be the lowest of
financial ratios. The total debt amount that will be restructured is USD 37,358,546 which part of the debt, USD 32,934,250, will be converted into equity while the remaining will be recorded as gain from debt
December 2018, compared to 10.18% as of 31 December 2017. Net debt to equity was 0.12%, compared to 0.10% as of 31 December 2017. (Unit : Baht million) 31 DEC 18 31 DEC 17 Change Total assets 968.30 900.31
million) 31 DEC 19 31 DEC 18 Change Total assets 1093.46 968.30 12.93% Total liabilities 139.52 106.31 31.24% Total shareholder’s equity 911.06 855.08 6.55% Net debt to equity (D/E Ratio) 0.15 0.12 - Return
greater export sales portion. 3. In Q3 2017, the Company and its subsidiaries recorded the assets’ impairment loss and write- off of Solvay Biochemicals (Taixing) Limited (“SBT”) net amounting to 132 MB
(ROE) ratio was 4.93% and Net Debt to Equity ratio was 0.18 as of 31 March 2019. (Unit : Baht million) 31 MAR 19 (quarterly) 31 DEC 18 (yearly) Change Total Assets 1,068.05 968.30 10.30% Total